Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases.
Journal Information
Full Title: Br J Cancer
Abbreviation: Br J Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding We appreciate the financial supports by the National Natural Science Foundationof China (Grant Number: 82072937, 82072897, 82002773), Innovative Research Team ofHigh-Level Local Universities in Shanghai (SHSMU-ZDCX20212200), ShanghaiMunicipal Education Commission-Gaofeng Clinical Medicine Grant Support (20172007),and Scientific research project of Shanghai Municipal Health Commission(20194Y0419). All these financial sponsors had no role in the study design, collection, analysis orinterpretation of data."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025